Literature DB >> 29475933

Association of Diaphragmatic Surgery as Part of Cytoreductive Effort in Advanced Stage Ovarian Cancer.

Nicolae Bacalbasa1, Irina Balescu2, Cristian Balalau1,3, Olivia Ionescu4, Claudia Stoica5.   

Abstract

BACKGROUND/AIM: Diaphragmatic surgery in advanced-stage ovarian cancer has been considered since long time to increase the rates of postoperative complications. However, improvement of surgical techniques and perioperative management of these patients has lead in the last decade to a safe association of such procedures as part of debulking process. The aim of the current paper was to report our experience regarding the role of diaphragmatic resections as part of debulking surgery for advanced stage ovarian cancer.
MATERIALS AND METHODS: Between 2014 and 2016 diaphragmatic surgery was performed in 22 cases with advanced stage ovarian cancer.
RESULTS: Diaphragmatic surgery consisted of diaphragmatic peritoneal resection in 10 cases, full thickness diaphragmatic resections in four cases and coagulation of peritoneal nodules in eight cases. In all but two cases debulking surgery to no residual disease was achieved. Other upper abdominal resections consisted of splenectomy - in four cases, liver resections - in three cases, glissonian capsule resections - in eight cases, distal pancreatectomy - in one case and partial gastrectomies in two cases. The postoperative outcomes were similar irrespective of type of diaphragmatic surgical procedure.
CONCLUSION: Diaphragmatic surgery is a crucial procedure which can be safely associated as part of debulking surgery for advanced stage ovarian cancer. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Advanced-stage ovarian cancer; diaphragmatic peritonectomy; diaphragmatic resection

Mesh:

Substances:

Year:  2018        PMID: 29475933      PMCID: PMC5905218          DOI: 10.21873/invivo.11258

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  19 in total

1.  Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

Authors:  S M Eisenkop; N M Spirtos
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

2.  Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.

Authors:  Sebastien Gouy; Elisabeth Chereau; Ana Sofia Custodio; Catherine Uzan; Patricia Pautier; Christine Haie-Meder; Pierre Duvillard; Philippe Morice
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

3.  Diaphragmatic Surgery in Advanced Ovarian, Tubal and Peritoneal Cancer. A 7-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.

Authors:  Mustafa Zelal Muallem; Jumana Almuheimid; Rolf Richter; Elena Ioana Braicu; Suzan Osman; Jalid Sehouli
Journal:  Anticancer Res       Date:  2016-09       Impact factor: 2.480

4.  Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery.

Authors:  Francesco Fanfani; Anna Fagotti; Valerio Gallotta; Alfredo Ercoli; Fabio Pacelli; Barbara Costantini; Giuseppe Vizzielli; Pasquale Alessandro Margariti; Giorgia Garganese; Giovanni Scambia
Journal:  Gynecol Oncol       Date:  2009-12-11       Impact factor: 5.482

5.  Hepatic Resection for Liver Metastases from Cervical Cancer Is Safe and May Have Survival Benefit.

Authors:  Nicolae Bacalbasa; Irina Balescu; Simona Dima; Irinel Popescu
Journal:  Anticancer Res       Date:  2016-06       Impact factor: 2.480

6.  Maximal cytoreductive effort in epithelial ovarian cancer surgery.

Authors:  Karin K Shih; Dennis S Chi
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

7.  Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis.

Authors:  Hooman Soleymani Majd; Federico Ferrari; Sanjiv Manek; Kumar Gubbala; Riccardo Garruto Campanile; Kieran Hardern; Roberto Tozzi
Journal:  Gynecol Oncol       Date:  2015-12-12       Impact factor: 5.482

8.  Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience.

Authors:  Nicolae Bacalbasa; Simona Dima; Irina Balescu; Leonard David; Vladislav Brasoveanu; Irinel Popescu
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

9.  Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.

Authors:  Nicolae Bacalbasa; Irina Balescu; Simona Dima; Vladislav Brasoveanu; Irinel Popescu
Journal:  Anticancer Res       Date:  2015-10       Impact factor: 2.480

10.  Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases.

Authors:  Nicolae Bacalbaşa; Irina Balescu; Simona Dima; Irinel Popescu
Journal:  Anticancer Res       Date:  2015-12       Impact factor: 2.480

View more
  2 in total

1.  Right Upper Abdominal Resections in Advanced Stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Camelia Diaconu; Laura Iliescu; Alexandru Filipescu; Irina Balescu; Cora Pop; Simona Dima; Mihaela Vilcu; Iulian Brezean
Journal:  In Vivo       Date:  2020-04-29       Impact factor: 2.155

2.  Application of J-Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer.

Authors:  Vasilios Theodoulidis; Anastasia Prodromidou; Emmanouil Stamatakis; Nicholas Alexakis; Alexandros Rodolakis; Dimitrios Haidopoulos
Journal:  Mol Clin Oncol       Date:  2022-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.